XPhyto Therapeutics and German partner complete successful validation of their COVID-19 RT-PCR test system

XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF (FSE:4XT) and its exclusive German diagnostics development partner 3a-diagnostics GmbH announced Thursday the successful validation of their point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system.  In addition, XPhyto said European regulatory approval and commercial product launch in European markets are planned for the first quarter of 2021.  The newly developed test system has demonstrated diagnostic level accuracy (sensitivity and specificity) in its ability to detect SARS-CoV-2 RNA within 25 minutes. Robustness, repeatability, and laboratory precision have also been confirmed. The test is designed to be conducted with only minimal laboratory processes and equipment.  READ: XPhyto taps European healthcare veteran Per S Thoresen as director as it eyes commercialization "Successful test validation is a critical milestone on the pathway to accelerated commercialization," said XPhyto CEO Hugh Rogers in a statement. "With no need for large, specialized laboratories, our system is particularly well suited for point-of-care testing. We believe this will provide increased speed, convenience, and flexibility for the immediate identification of infected people in a wider variety of settings through the use of satellite and mobile labs." The company said it will provide further details on the validation results and methodology, regulatory approval process, and commercialization strategy in due course. XPhyto maintains that it is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 pandemic. Vancouver-based XPhyto is a science-focused cannabis company developing analytical testing, processing, and formulation capability in Canada, while in Germany, it is focused on research, cultivation, extraction, import, distribution, and manufacturing. Contact the author: patrick@proactiveinvestors.com Follow him on Twitter @PatrickMGraham